Cover Image

Novel Aminopyrimidine-2,4-diones, 2-Thiopyrimidine-4-ones, and 6-Arylpteridines as Dual-Target Inhibitors of BRD4/PLK1: Design, Synthesis, Cytotoxicity, and Computational Studies

Structural-based drug design and solvent-free synthesis were combined to obtain three novel series of 5-arylethylidene-aminopyrimidine-2,4-diones (<b>4</b>, <b>5a</b>-<b>c</b>, <b>6a</b>,<b>b</b>), 5-arylethylidene-amino-2-thiopyrimidine-4-...

Full description

Saved in:

Bibliographic Details
Main Authors:	Samar El-Kalyoubi (Author), Samiha A. El-Sebaey (Author), Sherin M. Elfeky (Author), Hanan A. AL-Ghulikah (Author), Mona S. El-Zoghbi (Author)
Format:	Book
Published:	MDPI AG, 2023-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Synthesis, DFT calculations, and anti-proliferative evaluation of pyrimidine and selenadiazolopyrimidine derivatives as dual Topoisomerase II and HSP90 inhibitors
by: Samar El-Kalyoubi, et al.
Published: (2023)

Design, synthesis, docking, and anticancer evaluations of new thiazolo[3,2-a] pyrimidines as topoisomerase II inhibitors
by: Mona S. El-Zoghbi, et al.
Published: (2023)

Novel pyrimidine Schiff bases and their selenium-containing nanoparticles as dual inhibitors of CDK1 and tubulin polymerase: design, synthesis, anti-proliferative evaluation, and molecular modelling
by: Samar El-Kalyoubi, et al.
Published: (2023)

Synthesis of Nitrostyrylthiazolidine-2,4-dione Derivatives Displaying Antileishmanial Potential
by: Omar Khoumeri, et al.
Published: (2024)

Novel Thiazolidine-2,4-dione-trimethoxybenzene-thiazole Hybrids as Human Topoisomerases Inhibitors
by: Maria Stefania Sinicropi, et al.
Published: (2023)

Synthesis and acute toxicity of new S-derivatives (1,2,4-triazole-3(2H)-yl)methyl) thiopyrimidines
by: Yu. V. Karpenko, et al.
Published: (2023)

Searching for new cytotoxic agents based on chromen-4-one and chromane-2,4-dione scaffolds
by: Alexandra Gaspar, et al.
Published: (2019)

Search for antibacterial activity in a number of new S-derivatives (1,2,4-triazole-3(2H)-yl)methyl)thiopyrimidines
by: Yu. V. Karpenko, et al.
Published: (2021)

BRD4: an effective target for organ fibrosis
by: Qun Wei, et al.
Published: (2024)

Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis
by: Zhangxu He, et al.
Published: (2022)

Synthesis and in vitro antiproliferative and antibacterial activity of new thiazolidine-2,4-dione derivatives
by: Nazar Trotsko, et al.
Published: (2018)

BRD4: New hope in the battle against glioblastoma
by: Weichen Duan, et al.
Published: (2023)

Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents
by: Monika Marcinkowska, et al.
Published: (2018)

Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists
by: Mohamed A. Abdelgawad, et al.
Published: (2022)

Search for molecular descriptors and computer prediction of biological activity in a series of S-derivatives (1,2,4-triazole-3(2H)-yl)methyl)thiopyrimidines
by: Yu. V. Karpenko, et al.
Published: (2024)

Discovery of the natural product 3',4',7,8-tetrahydroxyflavone as a novel and potent selective BRD4 bromodomain 2 inhibitor
by: Jiao Li, et al.
Published: (2021)

Synthesis and antibacterial activity of new (2,4-dioxothiazolidin-5-yl/ylidene)acetic acid derivatives with thiazolidine-2,4-dione, rhodanine and 2-thiohydantoin moieties
by: Nazar Trotsko, et al.
Published: (2018)

Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies
by: Mohammed S. Taghour, et al.
Published: (2022)

BRD4 promotes gouty arthritis through MDM2-mediated PPARγ degradation and pyroptosis
by: Xiaoxia Xu, et al.
Published: (2024)

Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligands
by: Sadek B, et al.
Published: (2014)

Synthesis and Biological Evaluation of a Series of New Hybrid Amide Derivatives of Triazole and Thiazolidine-2,4-dione
by: Igor B. Levshin, et al.
Published: (2024)

A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression
by: Zijun Zhou, et al.
Published: (2020)

Synthesis, anticancer, apoptosis-inducing activities and EGFR and VEGFR2 assay mechanistic studies of 5,5-diphenylimidazolidine-2,4-dione derivatives: Molecular docking studies
by: Hamad M. Alkahtani, et al.
Published: (2019)

Design, synthesis, and evaluation of 4-(3-(3,5-dimethylisoxazol-4-yl)benzyl)phthalazin-1(2H)-one derivatives: potent BRD4 inhibitors with anti-breast cancer activity
by: Yingpeng Li, et al.
Published: (2023)

New benzothieno[2,3-c]pyridines as non-steroidal CYP17 inhibitors: design, synthesis, anticancer screening, apoptosis induction, and in silico ADME profile studies
by: Nadia A. Khalil, et al.
Published: (2021)

Natural intestinal metabolite xylitol reduces BRD4 levels to mitigate renal fibrosis
by: Zhouke Tan, et al.
Published: (2024)

Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights
by: Abdelrahman Hamdi, et al.
Published: (2023)

Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold
by: Qingwei Zhang, et al.
Published: (2020)

Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold
by: Qingwei Zhang, et al.
Published: (2020)

BRD4 Inhibition Protects Against Acute Pancreatitis Through Restoring Impaired Autophagic Flux
by: Shuangjun Shen, et al.
Published: (2020)

A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization
by: Tingting Yang, et al.
Published: (2022)

2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione Ameliorates Diabetic Cognitive Impairment Through Inhibiting Hif3α and Apoptosis
by: Lihui Wang, et al.
Published: (2021)

Anti-Breast Cancer Effect of 2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione in vivo and in vitro Through MAPK Signaling Pathway
by: Zhou X, et al.
Published: (2020)

BRD4 Targets the KEAP1-Nrf2-G6PD Axis and Suppresses Redox Metabolism in Small Cell Lung Cancer
by: Yang Lv, et al.
Published: (2022)

Sinapic Acid Reduces Oxidative Stress and Pyroptosis via Inhibition of BRD4 in Alcoholic Liver Disease
by: Junyi Chu, et al.
Published: (2021)

Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway
by: Li H, et al.
Published: (2022)

Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB-P300-BRD4 axis
by: Xuesong Li, et al.
Published: (2022)

Targeting mechanotransduction at the transcriptional level: YAP and BRD4 are novel therapeutic targets for the reversal of liver fibrosis
by: Altynbek Zhubanchaliyev, et al.
Published: (2016)

Discovery of novel coumarin derivatives as potent and orally bioavailable BRD4 inhibitors based on scaffold hopping
by: Zhimin Zhang, et al.
Published: (2019)

The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy
by: Zhenzhen Li, et al.
Published: (2021)